SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 147 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 3.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $576,000 | +4.0% | 87,600 | +0.5% | 0.43% | +18.7% |
| Q1 2016 | $554,000 | +12.6% | 87,158 | +6.8% | 0.36% | +78.8% |
| Q4 2015 | $492,000 | -17.2% | 81,584 | -17.9% | 0.20% | -6.9% |
| Q3 2015 | $594,000 | -9.3% | 99,348 | +3.8% | 0.22% | +44.4% |
| Q2 2015 | $655,000 | -36.9% | 95,693 | -44.1% | 0.15% | -21.4% |
| Q1 2015 | $1,038,000 | -32.0% | 171,058 | -22.3% | 0.19% | -30.9% |
| Q4 2014 | $1,526,000 | -7.2% | 220,160 | +9.0% | 0.28% | -6.7% |
| Q3 2014 | $1,645,000 | +67.9% | 202,068 | +67.6% | 0.30% | +91.0% |
| Q2 2014 | $980,000 | +161.3% | 120,543 | +151.8% | 0.16% | +188.9% |
| Q1 2014 | $375,000 | +31.1% | 47,874 | +47.9% | 0.05% | +35.0% |
| Q4 2013 | $286,000 | +7.5% | 32,371 | +2.2% | 0.04% | -4.8% |
| Q3 2013 | $266,000 | +14.2% | 31,685 | +1.2% | 0.04% | +2.4% |
| Q2 2013 | $233,000 | – | 31,295 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
| ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
| NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
| Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
| Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
| Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
| J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
| J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
| Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |